Advantages of External Reviews and Audits in Biopharmaceutical Product Development →

Gerald L. Klein, MD (MedSurgPI), Celine Clive (Polaris Compliance Consultants), 

Peter C. Johnson, MD (MedSurgPI), Laurie Meehan (Polaris Compliance Consultants), 

          Roger Morgan, MD  (MedSurgPI) and Valerie Riddle, MD

Building Trust in Pharmaceutical Analytics →

David Lengacher (Rx Solutions), Gerald L. Klein, MD (MedSurgPI LLC), Peter C. Johnson, MD (MedSurgPI, LLC), Roger E. Morgan MD (MedSurgPI, LLC), Valerie Riddle MD and Brent Walter (Rx Solutions)

The Integrated Management Role of the Chief Executive Officer and the Commercial Chief Medical Officer →

Peter C. Johnson, MD*, June S. Almenoff, MD**, PhD and Gerald L. Klein, MD*

MedSurgPI, LLC*, Raleigh, NC and ** Independent Drug Development Consultant, Durham, NC*

The Experienced Medical Monitor: The Role of Virtual and Commercial Medical Monitor →

By Roger E. Morgan MD, Gerald L. Klein, MD, and Peter C. Johnson, MD

Facilitating the Biomedical Key Opinion Leader (KOL) Meeting with a Commercial Chief Medical Officer (CCMO) →

Peter C. Johnson, MD, Gerald L. Klein, MD, Roger E. Morgan, MD MedSurgPI, Raleigh, NC

The Carmen Effect - And the Tyranny of Jargon →

Peter C. Johnson, MD

The New C-Suite →

Peter C. Johnson, MD*, Matthew J. Pattison**, MSc, Jan Creidenberg***, Gerald L. Klein, MD*

*    MedSurgPI, LLC, Raleigh, NC

**   Anatomy HCD, Ltd, Brighton, UK

*** Strand Hill Resources, LLC, Kansas City, MO

DECREASING THE COSTS AND RISKS OF DRUG, DEVICE, AND DIAGNOSTIC DEVELOPMENT WITH A VIRTUAL MEDICAL OFFICER (VMO)

Read Full Article

Gerald L. Klein, MD, Peter J. Johnson, MD, and Roger Morgan, MD

Medical Foods →

Gerald Klein, MD, Peter C. Johnson, MD and Renu Jain, PhD

Medical Officer Function in Startups →

Peter C. Johnson, MD and Gerald L. Klein, MD